Clinical Trials Browser

OTHER_GOV × Interventional × Adenocarcinoma of Lung × Clear all

NCT06796816 2025-01-28

BIVA-18

Phase NA Recruiting

Adenocarcinoma of Lung, Lung Neoplasms, Sarcopenia

NCT05675033 2023-01-09

Serplulimab Combined With Anti-VEGF Antibody in Advanced Lung Adenocarcinoma

Phase 2 Unknown

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

NCT02621333 2021-05-12

Chemotherapy Combined Autologous Cytokine-induced Killer Cells in Naive Stage IV EGFR-wild Type Lung Adenocarcinoma

Phase 2 Terminated

Adenocarcinoma of Lung

NCT02737774 2020-07-01

Alternating Icotinib and Chemotherapy for Advanced Non-small Cell Lung Cancer With EGFR Mutation

Phase 2 Unknown

Adenocarcinoma of Lung

NCT03486496 2018-04-03

Geber

Phase 2 Unknown

Adenocarcinoma of Lung

NCT02804646 2016-06-21

Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma

Phase 4 Unknown

Adenocarcinoma of Lung

NCT01502202 2012-06-20

Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never Smokers

Phase 2 Unknown

Adenocarcinoma of Lung, Adenocarcinoma, Carcinoma, Non-Small-Cell Lung